
Biktarvy
Bictegravir, Emtricitabine, Tenofovir Alafenamide
50mg + 200mg + 25mg
Bictegravir and emtricitabine tablets for HIV-1 infection. Two antiretrovirals work together to stop the virus from copying itself and spreading.
HIV ManagementAntiretroviral tablets and combination regimens for HIV-1 infection, including well-known names like Biktarvy, Tivicay and Tenvir-em alongside older single-ingredient options such as Epivir and Retrovir.

Bictegravir, Emtricitabine, Tenofovir Alafenamide
50mg + 200mg + 25mg
Bictegravir and emtricitabine tablets for HIV-1 infection. Two antiretrovirals work together to stop the virus from copying itself and spreading.

Tenofovir Disoproxil, Emtricitabine
300mg + 200mg
Tenofovir and emtricitabine tablets for HIV and pre-exposure prophylaxis. Combining two antivirals lowers the risk of resistance.

Emtricitabine, Tenofovir Disoproxil, Efavirenz
1.1gm
Efavirenz, emtricitabine and tenofovir tablets for HIV-1 infection. Combining three antiretrovirals lowers the chance of resistance.

Dolutegravir, Lamivudine, Tenofovir Disoproxil
50mg + 300mg + 300mg
Dolutegravir and lamivudine tablets for HIV-1 infection. It blocks two different steps in the HIV lifecycle.

Tenofovir Disoproxil, Efavirenz, Emtricitabine
300mg + 600mg + 200mg
Tenofovir disoproxil and efavirenz tablets for HIV-1. They combine two antiretrovirals to keep the virus in check.

400mg
Indinavir capsules for HIV-1 infection. It stops the virus from maturing into infectious particles.
Several tablets combine antiretroviral therapy into a combination regimen in a single pill: Biktarvy combines bictegravir, emtricitabine and tenofovir alafenamide, while Viraday and Trustiva combine efavirenz, Emtricitabine and Tenofovir Disoproxil. Viropil uses a different three-ingredient combination, pairing dolutegravir and lamivudine with tenofovir disoproxil. Other tablets carry a single active ingredient, among them Tivicay (dolutegravir), Sustiva (Efavirenz) and Epivir (lamivudine), or a two-ingredient pairing such as Combivir (lamivudine and zidovudine) and Tenvir-em (tenofovir disoproxil and emtricitabine). Tenvir-em’s attached indications also include Pre-exposure Prophylaxis, alongside its role in treating existing HIV-1 infection.